According to Renovaro Biosciences's latest financial reports the company's current earnings (TTM) are -$53.93 M. In 2023 the company made an earning of -$41.24 M an increase over its 2022 earnings that were of -$0.11 B.The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.